The clinical indications and roles of LHRH-gtimulating test were discussed.
本文对LHRH兴奋试验的临床价值及适应症进行了讨论。
Conclusion LHRH - PE40 can inhibit the growth of solid tumors in tumor-bearing mice.
结论LHRH-PE40可以有效地抑制荷瘤小鼠实体瘤的生长。
Conclusions LHRH-PE40 has obvious inhibition effect on the proliferation of gastric cell lines.
结论免疫毒素LHRH - PE40对胃癌细胞的增殖状态有明显的抑制作用。
There were characteristic changes in their reactive curve in response to LHRH-stimulating test;
其LHRH兴奋试验的反应曲线具有特征性的改变；
As with all LHRH agonists, triptorelin causes an initial transient increase in testosterone levels.
正如所有释放激素激动剂，曲普瑞林导致睾酮水平在最初的短暂上升。
In 2001, the best-selling oncology drug was the LHRH analog goserelin, with estimated sales of over $1 billion.
2001年，销量最大的肿瘤药物是LHRH类似物戈舍瑞林（goserelin），预计年销售额超过10亿美元。
Results LHRH-PE40 significantly inhibited the proliferation and induced the apoptosis of gastric carcinoma cell line BGC-823.
结果免疫毒素LHRH-PE40对人胃癌细胞系B GC-823的增殖有明显的抑制作用，同时促进了细胞的凋亡。
The test of histamine release (HRT) from rat mast cell is one of the methods used to evaluate the anaphylactoid activity of LHRH antagonists.
本文主要报道了自行合成的九种LHRH拮抗类似物的组胺释放作用的评价方法。
Methods The cytotoxic activity of LHRH-PE40 to the human tumor cell lines cultured in vitro was detected by MTT method, and sensitive tumor cell lines were selected out.
方法用MTT检恻LHRH-PE40对体外培养的人肿瘤细胞的细胞毒作用，找出敏感肿瘤细胞系。
LHRH agonists provide an additional class of agents for treatment of premenopausal women with hormone-receptor-positive breast cancer. Optimum duration of use is unknown.
LHRH激动剂为激素受体阳性的绝经前乳腺癌女性患者提供了一种附加的治疗手段。最佳服用时限仍未知。
Results: LHRH analogues had extensive clinical applications and the main formulations were implants and microspheres. Microspheres had much broader advantages over implants.
结果：LHRH类似物的药理作用较为广泛，其剂型主要为埋植剂和微球，二者相比，微球制剂具有更大的优势。
Results: LHRH analogues had extensive clinical applications and the main formulations were implants and microspheres. Microspheres had much broader advantages over implants.
结果：LHRH类似物的药理作用较为广泛，其剂型主要为埋植剂和微球，二者相比，微球制剂具有更大的优势。
应用推荐